The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease

被引:6
作者
Edith Aguilar-Olivos, Nancy [1 ]
Oria-Hernandez, Jesus [2 ]
Ponciano-Rodriguez, Guadalupe [3 ]
Carlos Chavez-Tapia, Norberto [4 ]
Uribe, Misael [4 ]
Mendez-Sanchez, Nahum [1 ]
机构
[1] Medica Sur Clin & Fdn, Liver Res Unit, Mexico City 14050, DF, Mexico
[2] Minist Hlth, Natl Inst Pediat, Biochem & Genet Lab, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Med, Dept Publ Hlth, Mexico City 04510, DF, Mexico
[4] Medica Sur Clin & Fdn, Obes & Digest Dis Unit, Mexico City 14050, DF, Mexico
关键词
Biological markers; disease progression; DNA methylation; histones; liver; microRNAs; one-carbon metabolism; NICOTINAMIDE-N-METHYLTRANSFERASE; ATP-CITRATE LYASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; SIRT1; STEATOHEPATITIS; METABOLISM; MICE; METHYLATION; MICRORNAS;
D O I
10.2174/1389557515666150709115702
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-alcoholic fatty liver disease encompasses a spectrum of pathologies ranging from simple steatosis to non-alcoholic steatohepatitis. Patients with non-alcoholic steatohepatitis have increased risk of cirrhosis, liver failure and hepatocellular carcinoma. About 25% of subjects with simple steatosis progress to steatohepatitis; nowadays, the detailed pathological factors influencing the progression of non-alcoholic fatty liver disease remains unclear. It is proposed that genetic and environmental factors interact to determine the disease phenotype. Epigenetics could explain some relationships between genes and external influences. The epigenetic changes that have been related to non-alcoholic fatty liver disease are DNA methylation, one-carbon metabolism, histone modifications and the presence of micro-RNA. DNA methylation and micro-RNAs have been investigated in human samples, whereas histone modifications have only been studied until now in animal and cellular models. The aim of this study is to review the most relevant information about epigenetic changes in non-alcoholic steatohepatitis.
引用
收藏
页码:1187 / 1194
页数:8
相关论文
共 50 条
  • [1] Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non-alcoholic fatty liver disease
    Guha, Shreyoshi
    Sesili, Selvam
    Mir, Ishfaq Hassan
    Thirunavukkarasu, Chinnasamy
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (01) : 4 - 19
  • [2] Non-alcoholic fatty liver disease establishment and progression: genetics and epigenetics as relevant modulators of the pathology
    Pansa, Camila Cristiane
    Molica, Leticia Ramos
    Moraes, Karen C. M.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (05) : 521 - 533
  • [3] Epigenetics in non-alcoholic fatty liver disease
    Lee, Jooho
    Kim, Yuri
    Friso, Simonetta
    Choi, Sang-Woon
    MOLECULAR ASPECTS OF MEDICINE, 2017, 54 : 78 - 88
  • [4] The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
    Hliwa, Aleksandra
    Ramos-Molina, Bruno
    Laski, Dariusz
    Mika, Adriana
    Sledzinski, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [5] Macrophages and the development and progression of non-alcoholic fatty liver disease
    Alabdulaali, Bader
    Al-rashed, Fatema
    Al-Onaizi, Mohammed
    Kandari, Anwar
    Razafiarison, Joanna
    Tonui, Dorothy
    Williams, Michayla R.
    Bleriot, Camille
    Ahmad, Rasheed
    Alzaid, Fawaz
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease
    Winarto, Jessica
    Song, Dae-Geun
    Pan, Cheol-Ho
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [7] The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
    Tilg, Herbert
    DIGESTIVE DISEASES, 2010, 28 (01) : 179 - 185
  • [8] Role of Leptin in Non-Alcoholic Fatty Liver Disease
    Jimenez-Cortegana, Carlos
    Garcia-Galey, Alba
    Tami, Malika
    del Pino, Pilar
    Carmona, Isabel
    Lopez, Soledad
    Alba, Gonzalo
    Sanchez-Margalet, Victor
    BIOMEDICINES, 2021, 9 (07)
  • [9] Genetic modifiers of non-alcoholic fatty liver disease progression
    Anstee, Quentin M.
    Daly, Ann K.
    Day, Christopher P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (11): : 1557 - 1566
  • [10] Lipidomics in non-alcoholic fatty liver disease
    Kartsoli, Sofia
    Kostara, Christina E.
    Tsimihodimos, Vasilis
    Bairaktari, Eleni T.
    Christodoulou, Dimitrios K.
    WORLD JOURNAL OF HEPATOLOGY, 2020, 12 (08) : 436 - 450